Cargando…
Pharmacological TLR4 Inhibition Protects against Acute and Chronic Fat-Induced Insulin Resistance in Rats
AIMS: To evaluate whether pharmacological TLR4 inhibition protects against acute and chronic fat-induced insulin resistance in rats. MATERIALS AND METHODS: For the acute experiment, rats received a TLR4 inhibitor [TAK-242 or E5564 (2x5 mg/kg i.v. bolus)] or vehicle, and an 8-h Intralipid (20%, 8.5 m...
Autores principales: | Zhang, Ning, Liang, Hanyu, Farese, Robert V., Li, Ji, Musi, Nicolas, Hussey, Sophie E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510579/ https://www.ncbi.nlm.nih.gov/pubmed/26196892 http://dx.doi.org/10.1371/journal.pone.0132575 |
Ejemplares similares
-
EFFECT OF TLR4 INHIBITION IN FAT-INDUCED INSULIN RESISTANCE IN HUMAN SUBJECTS
por: Liang, Hanyu, et al.
Publicado: (2019) -
Effect of acute TLR4 inhibition on insulin resistance in humans
por: Liang, Hanyu, et al.
Publicado: (2022) -
Effect of Lipopolysaccharide on Inflammation and Insulin Action in Human Muscle
por: Liang, Hanyu, et al.
Publicado: (2013) -
TAK-242, a small-molecule inhibitor of Toll-like receptor 4 signalling, unveils similarities and differences in lipopolysaccharide- and lipidinduced inflammation and insulin resistance in muscle cells
por: Hussey, Sophie E., et al.
Publicado: (2012) -
Pharmacological inhibition of TLR4-NOX4 signal protects against neuronal death in transient focal ischemia
por: Suzuki, Yukiya, et al.
Publicado: (2012)